SCHEMBL132392

SCHEMBL132392

C#CC1(N)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21198396 0.94
SCHEMBL23044704 0.90
SCHEMBL10577681 0.87
SCHEMBL17074258 0.83
Hydrochloric Acid SCHEMBL17824823 0.80
SCHEMBL277257 0.73 TSHR (0.33)
SCHEMBL21218860 0.71
Hydrochloric Acid SCHEMBL21198617 0.69
SCHEMBL3754905 0.69
SCHEMBL4355800 0.69 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 678 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114031974-A Ink for ink jet printing and electroluminescent device 广东聚华印刷显示技术有限公司 2022-02-11 CN claimed
US-9868820-B2 Polyarylene materials ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2018-01-16 US claimed
US-8198332-B2 Salicylamide derivatives as nicotinic alpha 7 modulators ROCHE PALO ALTO LLC (US) 2012-06-12 US claimed
EP-2323971-B1 SALICYLAMIDE DERIVATIVES AS NICOTINIC ALPHA 7 MODULATORS HOFFMANN LA ROCHE (CH) 2012-05-09 EP claimed
US-20100041763-A1 Salicylamide derivatives as nicotinic alpha 7 modulators ROCHE PALO ALTO LLC 2010-02-18 US claimed
WO-2010018095-A1 SALICYLAMIDE DERIVATIVES AS NICOTINIC ALPHA 7 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-02-18 WO claimed
US-20090264412-A1 Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy HIGH POINT PHARMACEUTICALS, LLC (US) 2009-10-22 US claimed
US-20090137574-A1 Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders NOVO NORDISK A/S (DK) 2009-05-28 US claimed
EP-1502292-A4 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE INC (US) 2009-01-21 EP claimed
EP-1633348-B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARM INC (US) 2008-10-08 EP claimed
WO-2004089470-A2 NEW AMIDE DERIVATIVES AND PHARMACEUTICAL USE THEREOF NOVO NORDISK A/S (DK) 2004-10-21 WO claimed
WO-2004089415-A2 COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST NOVO NORDISK A/S (DK) 2004-10-21 WO claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
US-20030224586-A1 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE, INC. 2003-12-04 US claimed
WO-2003094213-A1 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE, INC. (US) 2003-11-13 WO claimed
EP-0635508-B1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS ASAHI CHEMICAL IND (JP) 1999-10-06 EP claimed
EP-0635508-A1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1995-01-25 EP claimed
EP-0039787-B1 PREPARATION PROCESS OF CYCLOPENTADIENE COPOLYMERS BASF Aktiengesellschaft (DE) 1983-07-06 EP claimed
US-4371676-A FREE-RADICAL CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1983-02-01 US claimed
EP-0039787-A1 Preparation process of cyclopentadiene copolymers BASF Aktiengesellschaft (DE) 1981-11-18 EP claimed